Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(}function setPanelState(o){dom.root.classList[o?"add":"remove"](,dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Shlomo Booklin with a cannabis seedling at Tilray a medical marijuana grow-op in Nanaimo August 14, 2014. (John Lehmann/The Globe and Mail)

John Lehmann/The Globe and Mail

Medical marijuana is a legal drug in Canada. True, it is only supposed to be available to people with a doctor's prescription – but that can be said about hundreds of other pharmaceuticals. What's more, since there's no patent on pot, the easy-to-grow plant is really just a generic prescription drug. In Canada, all sorts of generic drugs are safely produced by drug companies, prescribed by doctors and sold by pharmacists. The system works.

Except when it comes to medical marijuana. A decade and a half after the Ontario Court of Appeal ordered the government to give access to pot to those in medical need, the matter is still not settled. The system is chaotic. Confusion reigns.

In response to the 2000 court decision, the government put in place new rules that essentially allowed some patients to grow their own drugs at home. In hindsight, this was probably not the ideal solution. Last year, Ottawa began to replace that problematic approach with one that sounds promising: Private businesses will be licensed to run grow-ops, producing legal, regulated, medical marijuana.

Story continues below advertisement

It works for alcohol. It works for other drugs. So why is the marijuana industry still in such a state of flux? And why is federal oversight of it still such a mess?

Hundreds of companies have applied to produce medical marijuana. The licensing process has been slow, confusing and opaque. And the promise of riches for those who secure a government contract has opened the doors to stock-market speculation not seen since the era.

As uncovered in a recent Globe and Mail investigation, CEN Biotech, a U.S.-based company whose stock trades over the counter, made numerous false claims to investors. The company, which says it wants to open the country's biggest grow-op in southwestern Ontario, on multiple occasions publicly misrepresented its licence status with Health Canada and suggested it was being favoured by the government. Health Canada's response has been to do nothing. The application is apparently still in process. The regulator isn't regulating.

It should be possible – in fact, it should be easy – for medical marijuana to be effectively regulated, overseen, produced, prescribed and sold. It's what happens with every other drug. Why is Health Canada finding this so difficult?

Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to If you want to write a letter to the editor, please forward to
Comments are closed

We have closed comments on this story for legal reasons or for abuse. For more information on our commenting policies and how our community-based moderation works, please read our Community Guidelines and our Terms and Conditions.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies